{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:31:01Z","timestamp":1792099861497,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB19000000"],"award-info":[{"award-number":["XDB19000000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To explain the excess cancer rate in males, several candidates for \u201cescape from X-inactivation tumor-suppressor\u201d (EXITS) were recently identified. In this report we provide direct experimental evidence supporting UTX\u2019s role as an EXITS gene. Using a mouse lymphoma model, we show clear dosage effect of UTX copy number during tumorigenesis, which strongly supports the EXITS theory. Importantly, UTX deletion not only accelerates lymphomagenesis, it also strongly promotes tumor progression. UTX-knockout tumors are more aggressive, showing enhanced brain dissemination and formation of blood vessels. Efnb1 is overexpressed in UTX KO tumors and can lead to such phenotypes. In human patients, lymphomas with low UTX expression also express high levels of Efnb1, and cause significantly poor survival. Lastly, we show that UTX deficiency renders lymphoma sensitive to cytarabine treatment. Taken together, these data highlight UTX loss\u2019s profound impacts on tumor initiation and drug response.<\/jats:p>","DOI":"10.1038\/s41467-018-05084-w","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T13:51:39Z","timestamp":1531144299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5399-5628","authenticated-orcid":false,"given":"Xiaoxi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie Degui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2508-5413","authenticated-orcid":false,"given":"Hai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,13]]},"reference":[{"key":"5084_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nature06145","volume":"449","author":"K Agger","year":"2007","unstructured":"Agger, K. et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449, 731\u2013734 (2007).","journal-title":"Nature"},{"key":"5084_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/ng.349","volume":"41","author":"G van Haaften","year":"2009","unstructured":"van Haaften, G. et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet. 41, 521\u2013523 (2009).","journal-title":"Nat. Genet."},{"key":"5084_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nature08672","volume":"463","author":"GL Dalgliesh","year":"2010","unstructured":"Dalgliesh, G. L. et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463, 360\u2013363 (2010).","journal-title":"Nature"},{"key":"5084_CR4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/ng.907","volume":"43","author":"Y Gui","year":"2011","unstructured":"Gui, Y. et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat. Genet. 43, 875\u2013878 (2011).","journal-title":"Nat. Genet."},{"key":"5084_CR5","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/leu.2012.56","volume":"26","author":"BG Mar","year":"2012","unstructured":"Mar, B. G. et al. Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia. Leukemia 26, 1881\u20131883 (2012).","journal-title":"Leukemia"},{"key":"5084_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1200\/JCO.2013.50.8556","volume":"32","author":"Y Kim","year":"2014","unstructured":"Kim, Y. et al. Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients. J. Clin. Oncol. 32, 121\u2013128 (2014).","journal-title":"J. Clin. Oncol."},{"key":"5084_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495\u2013501 (2015).","journal-title":"Nature"},{"key":"5084_CR8","doi-asserted-by":"publisher","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","volume":"45","author":"SA Forbes","year":"2017","unstructured":"Forbes, S. A. et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 45, D777\u2013D783 (2017).","journal-title":"Nucleic Acids Res."},{"key":"5084_CR9","doi-asserted-by":"publisher","first-page":"13004","DOI":"10.1073\/pnas.1210787109","volume":"109","author":"GG Welstead","year":"2012","unstructured":"Welstead, G. G. et al. X-linked H3K27me3 demethylase Utx is required for embryonic development in a sex-specific manner. Proc. Natl Acad. Sci. USA 109, 13004\u201313009 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5084_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature13605","volume":"514","author":"P Ntziachristos","year":"2014","unstructured":"Ntziachristos, P. et al. Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia. Nature 514, 513\u2013517 (2014).","journal-title":"Nature"},{"key":"5084_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2014-05-577270","volume":"125","author":"J Van der Meulen","year":"2015","unstructured":"Van der Meulen, J. et al. The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia. Blood 125, 13\u201321 (2015).","journal-title":"Blood"},{"key":"5084_CR12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/hmg\/7.4.737","volume":"7","author":"A Greenfield","year":"1998","unstructured":"Greenfield, A. et al. The UTX gene escapes X inactivation in mice and humans. Hum. Mol. Genet. 7, 737\u2013742 (1998).","journal-title":"Hum. Mol. Genet."},{"key":"5084_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/ng.3726","volume":"49","author":"A Dunford","year":"2017","unstructured":"Dunford, A. et al. Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nat. Genet. 49, 10\u201316 (2017).","journal-title":"Nat. Genet."},{"key":"5084_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc.2016.30","volume":"16","author":"A Clocchiatti","year":"2016","unstructured":"Clocchiatti, A., Cora, E., Zhang, Y. & Dotto, G. P. Sexual dimorphism in cancer. Nat. Rev. Cancer 16, 330\u2013339 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"5084_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz, R. et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490, 116\u2013120 (2012).","journal-title":"Nature"},{"key":"5084_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899\u2013905 (2010).","journal-title":"Nature"},{"key":"5084_CR17","doi-asserted-by":"publisher","first-page":"e74250","DOI":"10.1371\/journal.pone.0074250","volume":"8","author":"R Aguirre-Gamboa","year":"2013","unstructured":"Aguirre-Gamboa, R. et al. SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis. PLoS ONE 8, e74250 (2013).","journal-title":"PLoS ONE"},{"key":"5084_CR18","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"G Lenz","year":"2008","unstructured":"Lenz, G. et al. Stromal gene signatures in large-B-cell lymphomas. N. Engl. J. Med. 359, 2313\u20132323 (2008).","journal-title":"N. Engl. J. Med."},{"key":"5084_CR19","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1084\/jem.20030729","volume":"198","author":"T Tretter","year":"2003","unstructured":"Tretter, T., Ross, A. E., Dordai, D. I. & Desiderio, S. Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk. J. Exp. Med. 198, 1863\u20131873 (2003).","journal-title":"J. Exp. Med."},{"key":"5084_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature22353","volume":"546","author":"G Varano","year":"2017","unstructured":"Varano, G. et al. The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3beta inhibition. Nature 546, 302\u2013306 (2017).","journal-title":"Nature"},{"key":"5084_CR21","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.1073\/pnas.95.13.7351","volume":"95","author":"SN Malek","year":"1998","unstructured":"Malek, S. N., Dordai, D. I., Reim, J., Dintzis, H. & Desiderio, S. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase. Proc. Natl Acad. Sci. USA 95, 7351\u20137356 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5084_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrc2806","volume":"10","author":"EB Pasquale","year":"2010","unstructured":"Pasquale, E. B. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer 10, 165\u2013180 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"5084_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cell.2005.10.034","volume":"124","author":"SS Foo","year":"2006","unstructured":"Foo, S. S. et al. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124, 161\u2013173 (2006).","journal-title":"Cell"},{"key":"5084_CR24","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1073\/pnas.0401381101","volume":"101","author":"NK Noren","year":"2004","unstructured":"Noren, N. K., Lu, M., Freeman, A. L., Koolpe, M. & Pasquale, E. B. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc. Natl Acad. Sci. USA 101, 5583\u20135588 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5084_CR25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1158\/1078-0432.CCR-15-0603","volume":"22","author":"PD Dunne","year":"2016","unstructured":"Dunne, P. D. et al. EphA2 expression is a key driver of migration and invasion and a poor prognostic marker in colorectal cancer. Clin. Cancer Res. 22, 230\u2013242 (2016).","journal-title":"Clin. Cancer Res."},{"key":"5084_CR26","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.celrep.2017.09.078","volume":"21","author":"T Ezponda","year":"2017","unstructured":"Ezponda, T. et al. UTX\/KDM6A loss enhances the malignant phenotype of multiple myeloma and sensitizes cells to EZH2 inhibition. Cell Rep. 21, 628\u2013640 (2017).","journal-title":"Cell Rep."},{"key":"5084_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nchembio.503","volume":"7","author":"H Jiang","year":"2011","unstructured":"Jiang, H., Pritchard, J. R., Williams, R. T., Lauffenburger, D. A. & Hemann, M. T. A mammalian functional-genetic approach to characterizing cancer therapeutics. Nat. Chem. Biol. 7, 92\u2013100 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"5084_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nm.4247","volume":"23","author":"S Gollner","year":"2017","unstructured":"Gollner, S. et al. Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia. Nat. Med. 23, 69\u201378 (2017).","journal-title":"Nat. Med."},{"key":"5084_CR29","doi-asserted-by":"publisher","first-page":"18302","DOI":"10.1074\/jbc.M114.555052","volume":"289","author":"LJ Walport","year":"2014","unstructured":"Walport, L. J. et al. Human UTY(KDM6C) is a male-specific N-methyl lysyl demethylase. J. Biol. Chem. 289, 18302\u201318313 (2014).","journal-title":"J. Biol. Chem."},{"key":"5084_CR30","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1182\/blood-2012-08-452003","volume":"121","author":"S Thieme","year":"2013","unstructured":"Thieme, S. et al. The histone demethylase UTX regulates stem cell migration and hematopoiesis. Blood 121, 2462\u20132473 (2013).","journal-title":"Blood"},{"key":"5084_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000454890","volume":"137","author":"K Umino","year":"2017","unstructured":"Umino, K. et al. High-dose methotrexate and cytarabine-based multi-agent chemotherapy (modified bonn protocol) for systemic lymphoma with CNS involvement. Acta Haematol. 137, 93\u201399 (2017).","journal-title":"Acta Haematol."},{"key":"5084_CR32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00277-016-2648-4","volume":"95","author":"E Gonzalez-Barca","year":"2016","unstructured":"Gonzalez-Barca, E. et al. Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial. Ann. Hematol. 95, 893\u2013899 (2016).","journal-title":"Ann. Hematol."},{"key":"5084_CR33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(16)00739-X","volume":"388","author":"O Hermine","year":"2016","unstructured":"Hermine, O. et al. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Lancet 388, 565\u2013575 (2016).","journal-title":"Lancet"},{"key":"5084_CR34","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1101\/gad.13.20.2670","volume":"13","author":"CA Schmitt","year":"1999","unstructured":"Schmitt, C. A., McCurrach, M. E., de Stanchina, E., Wallace-Brodeur, R. R. & Lowe, S. W. INK4a\/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13, 2670\u20132677 (1999).","journal-title":"Genes Dev."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05084-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05084-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05084-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T15:53:09Z","timestamp":1671551589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05084-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["5084"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-05084-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,13]]},"assertion":[{"value":"14 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2720"}}